Skip to main content

Advertisement

SpringerLink
Log in

Obscure Involvement of MYC in Neurodegenerative Diseases and Neuronal Repair

  • Reviews
  • Published:
Molecular Neurobiology Aims and scope Submit manuscript

Abstract

MYC is well known as a potent oncogene involved in regulating cell cycle and metabolism. Augmented MYC expression leads to cell cycle dysregulation, intense cell proliferation, and carcinogenesis. Surprisingly, its increased expression in neurons does not induce their proliferation, but leads to neuronal cell death and consequent development of a neurodegenerative phenotype. Interestingly, while cancer and neurodegenerative diseases such as Alzheimer’s disease are placed at the opposite sides of cell division spectrum, both start with cell cycle dysregulation and stimulation of proliferation. It seems that MYC action directed toward neuron cell proliferation and neural tissue repair collides with evolutional loss of regenerative capacity of CNS neurons in order to strengthen synaptic structure, to protect our cognitive abilities and therefore character. Accordingly, there are abundant mechanisms that block its expression and action specifically in the brain. Moreover, while MYC expression in brain neurons during neurodegenerative processes is related to their death, there are obvious evidences that MYC action after physical injury is beneficial in case of peripheral nerve recovery. MYC might be a useful tool to repair brain cells upon development of neurodegenerative disease or CNS trauma, including stroke and traumatic brain and spinal cord injury, as even imperfect axonal growth and regeneration strategies will likely be of profound benefit. Understanding complex control of MYC action in the brain might have important therapeutic significance, but also it may contribute to the comprehension of development of neurodegenerative diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Krafts KP (2010) Tissue repair: the hidden drama. Organogenesis 6:225–233. https://doi.org/10.4161/org.6.4.12555

    Article  PubMed  PubMed Central  Google Scholar 

  2. Kalucka J, Missiaen R, Georgiadou M et al (2015) Metabolic control of the cell cycle. Cell Cycle 14:3379–3388. https://doi.org/10.1080/15384101.2015.1090068

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Fritz V, Fajas L (2010) Metabolism and proliferation share common regulatory pathways in cancer cells. Oncogene 29:4369–4377. https://doi.org/10.1038/onc.2010.182

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Conacci-Sorrell M, McFerrin L, Eisenman RN (2014) An overview of MYC and its interactome. Cold Spring Harb Perspect Med 4:1–24. https://doi.org/10.1101/cshperspect.a014357

    Article  CAS  Google Scholar 

  5. Nesbit CE, Tersak JM, Prochownik EV (1999) MYC oncogenes and human neoplastic disease. Oncogene 18:3004–3016. https://doi.org/10.1038/sj.onc.1202746

    Article  CAS  PubMed  Google Scholar 

  6. Pelengaris S, Khan M, Evan G (2002) c-MYC: more than just a matter of life and death. Nat Rev Cancer 2:764–776. https://doi.org/10.1038/nrc904

    Article  CAS  PubMed  Google Scholar 

  7. Lancho O, Herranz D (2018) The MYC Enhancer-ome: long-range transcriptional regulation of MYC in cancer. Trends in Cancer 4:810–822. https://doi.org/10.1016/j.trecan.2018.10.003

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Stine ZE, Walton ZE, Altman BJ et al (2015) MYC, metabolism, and cancer. Cancer Discov 5:1024–1039. https://doi.org/10.1158/2159-8290.CD-15-0507

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Dang CV (2012) MYC on the path to cancer. Cell 149:22–35. https://doi.org/10.1016/j.cell.2012.03.003

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Marinković D, Marinković T (2018) c-Myc misregulation triggers complex process of genomic instability. Genetika 50:731–745. https://doi.org/10.2298/GENSR1802731M

    Article  Google Scholar 

  11. Marinkovic D, Marinkovic T, Mahr B et al (2004) Reversible lymphomagenesis in conditionally c-MYC expressing mice. Int J Cancer 110:336–342. https://doi.org/10.1002/ijc.20099

    Article  CAS  PubMed  Google Scholar 

  12. Felsher DW, Bishop JM (1999) Reversible tumorigenesis by MYC in hematopoietic lineages. Mol Cell 4:199–207. https://doi.org/10.1016/S1097-2765(00)80367-6

    Article  CAS  PubMed  Google Scholar 

  13. Lee CVD, WM, (1999) c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol Cell Biol 19:1–11. https://doi.org/10.1128/mcb.19.1.1

    Article  Google Scholar 

  14. Kokai E, Voss F, Fleischer F et al (2009) Myc regulates embryonic vascular permeability and remodeling. Circ Res 104:1151–1159. https://doi.org/10.1161/CIRCRESAHA.108.191460

    Article  CAS  PubMed  Google Scholar 

  15. Casey SC, Baylot V, Felsher DW (2018) The MYC oncogene is a global regulator of the immune response. Blood 131:2007–2015. https://doi.org/10.1182/blood-2017-11-742577

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Marinkovic D, Marinkovic T (2020) The new role for an old guy: MYC as an immunoplayer. J Cell Physiol. https://doi.org/10.1002/jcp.30123

    Article  PubMed  Google Scholar 

  17. Kretzner L, Blackwood EM, Eisenman RN (1992) Myc and Max proteins possess distinct transcriptional activities. Nature 359:426–429. https://doi.org/10.1038/359426a0

    Article  CAS  PubMed  Google Scholar 

  18. Guo J, Li T, Schipper J et al (2014) Sequence specificity incompletely defines the genome-wide occupancy of Myc. Genome Biol 15:482. https://doi.org/10.1186/s13059-014-0482-3

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Schneider A, Peukert K, Eilers M, Hänel F (1997) Association of Myc with the zinc-finger protein Miz-1 defines a novel pathway for gene regulation by Myc. Curr Top Microbiol Immunol 224:137–146. https://doi.org/10.1007/978-3-642-60801-8_14

    Article  CAS  PubMed  Google Scholar 

  20. Von Der Lehr N, Johansson S, Wu S et al (2003) The F-box protein Skp2 participates in c-Myc proteosomal degradation and acts as a cofactor for c-Myc-regulated transcription. Mol Cell 11:1189–1200. https://doi.org/10.1016/S1097-2765(03)00193-X

    Article  PubMed  Google Scholar 

  21. Fernandez PC, Frank SR, Wang L et al (2003) Genomic targets of the human c-Myc protein. Genes Dev 17:1115–1129. https://doi.org/10.1101/gad.1067003

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Rahl PB, Young RA (2014) MYC and transcription elongation. Cold Spring Harb Perspect Med 4:a020990. https://doi.org/10.1101/cshperspect.a020990

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Zhang Y, Liu T, Meyer CA et al (2008) Model-based analysis of ChIP-Seq (MACS). Genome Biol 9:R137. https://doi.org/10.1186/gb-2008-9-9-r137

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Nie Z, Hu G, Wei G et al (2012) c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells. Cell 151:68–79. https://doi.org/10.1016/j.cell.2012.08.033

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Lin CY, Lovén J, Rahl PB et al (2012) Transcriptional amplification in tumor cells with elevated c-Myc. Cell 151:56–67. https://doi.org/10.1016/j.cell.2012.08.026

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Dang CV, O’Donnell KA, Zeller KI et al (2006) The c-Myc target gene network. Semin Cancer Biol 16:253–264. https://doi.org/10.1016/j.semcancer.2006.07.014

    Article  CAS  PubMed  Google Scholar 

  27. Shchors K, Shchors E, Rostker F et al (2006) The Myc-dependent angiogenic switch in tumors is mediated by interleukin 1β. Genes Dev 20:2527–2538. https://doi.org/10.1101/gad.1455706

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Kortlever RM, Sodir NM, Wilson CH et al (2017) Myc cooperates with Ras by programming inflammation and immune suppression. Cell 171:1301-1315.e14. https://doi.org/10.1016/j.cell.2017.11.013

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Bangert A, Cristofanon S, Eckhardt I et al (2012) Histone deacetylase inhibitors sensitize glioblastoma cells to TRAIL-induced apoptosis by c-myc-mediated downregulation of cFLIP. Oncogene 31:4677–4688. https://doi.org/10.1038/onc.2011.614

    Article  CAS  PubMed  Google Scholar 

  30. Vjetrovic J, Shankaranarayanan P, Mendoza-Parra MA, Gronemeyer H (2014) Senescence-secreted factors activate Myc and sensitize pretransformed cells to TRAIL-induced apoptosis. Aging Cell 13:487–496. https://doi.org/10.1111/acel.12197

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Bywater MJ, Burkhart DL, Straube J et al (2020) Reactivation of Myc transcription in the mouse heart unlocks its proliferative capacity. Nat Commun 11:1827. https://doi.org/10.1038/s41467-020-15552-x

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Lee HG, Casadesus G, Nunomura A et al (2009) The neuronal expression of MYC causes a neurodegenerative phenotype in a novel transgenic mouse. Am J Pathol 174:891–897. https://doi.org/10.2353/ajpath.2009.080583

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Lee H, gon, Casadesus G, Zhu X, et al (2009) Cell cycle re-entry mediated neurodegeneration and its treatment role in the pathogenesis of Alzheimer’s disease. Neurochem Int 54:84–88. https://doi.org/10.1016/j.neuint.2008.10.013

    Article  CAS  PubMed  Google Scholar 

  34. Nagy Z, Esiri MM, Smith AD (1997) Expression of cell division markers in the hippocampus in Alzheimer’s disease and other nenrodegenerative conditions. Acta Neuropathol 93:294–300. https://doi.org/10.1007/s004010050617

    Article  CAS  PubMed  Google Scholar 

  35. Zhu X, McShea A, Harris PLR et al (2004) Elevated expression of a regulator of the G2/M phase of the cell cycle, neuronal CIP-1-associated regulator of cyclin B, in Alzheimer’s disease. J Neurosci Res 75:698–703. https://doi.org/10.1002/jnr.20028

    Article  CAS  PubMed  Google Scholar 

  36. Mosch B, Morawski M, Mittag A et al (2007) Aneuploidy and DNA replication in the normal human brain and Alzheimer’s disease. J Neurosci 27:6859–6867. https://doi.org/10.1523/JNEUROSCI.0379-07.2007

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Yang Y, Geldmacher DS, Herrup K (2001) DNA replication precedes neuronal cell death in Alzheimer’s disease. J Neurosci 21:2661–2668. https://doi.org/10.1523/jneurosci.21-08-02661.2001

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Majd S, Zarifkar A, Rastegar K, Takhshid MA (2008) Different fibrillar Aβ 1–42 concentrations induce adult hippocampal neurons to reenter various phases of the cell cycle. Brain Res 1218:224–229. https://doi.org/10.1016/j.brainres.2008.04.050

    Article  CAS  PubMed  Google Scholar 

  39. Woods J, Snape M, Smith MA (2007) The cell cycle hypothesis of Alzheimer’s disease: suggestions for drug development. Biochim Biophys Acta - Mol Basis Dis 1772:503–508. https://doi.org/10.1016/j.bbadis.2006.12.004

    Article  CAS  Google Scholar 

  40. Snape M, Lee HG, Casadesus G, Smith MA (2009) Cell cycle aberrations in Alzheimer’s disease: a novel therapeutic opportunity. Expert Rev Neurother 9:1579–1580. https://doi.org/10.1586/ern.09.113

    Article  PubMed  Google Scholar 

  41. Lopes J, Oliveira C, Agostinho P (2009) Cell cycle re-entry in alzheimers disease: a major neuropathological characteristic? Curr Alzheimer Res 6:205–212. https://doi.org/10.2174/156720509788486590

    Article  CAS  PubMed  Google Scholar 

  42. Jordan-Sciutto KL, Dorsey R, Chalovich EM et al (2003) Expression patterns of retinoblastoma protein in Parkinson disease. J Neuropathol Exp Neurol 62:68–74. https://doi.org/10.1093/jnen/62.1.68

    Article  CAS  PubMed  Google Scholar 

  43. Ranganathan S, Bowser R (2003) Alterations in G1 to S phase cell-cycle regulators during amyotrophic lateral sclerosis. Am J Pathol 162:823–835. https://doi.org/10.1016/S0002-9440(10)63879-5

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Ferrer I, Blanco R, Carmona M, Puig B (2001) Phosphorylated c-MYC expression in Alzheimer disease, Pick’s disease, progressive supranuclear palsy and corticobasal degeneration. Neuropathol Appl Neurobiol 27:343–351. https://doi.org/10.1046/j.1365-2990.2001.00348.x

    Article  CAS  PubMed  Google Scholar 

  45. Ferrer I, Blanco R (2000) N-myc and c-myc expression in Alzheimer disease, Huntington disease and Parkinson disease. Mol Brain Res 77:270–276. https://doi.org/10.1016/S0169-328X(00)00062-0

    Article  CAS  PubMed  Google Scholar 

  46. Lee HP, Kudo W, Zhu X et al (2011) Early induction of c-Myc is associated with neuronal cell death. Neurosci Lett 505:124–127. https://doi.org/10.1016/j.neulet.2011.10.004

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Sleiman SF, Langley BC, Basso M et al (2011) Mithramycin is a gene-selective sp1 inhibitor that identifies a biological intersection between cancer and neurodegeneration. J Neurosci 31:6858–6870. https://doi.org/10.1523/JNEUROSCI.0710-11.2011

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Dhillon AS, Hagan S, Rath O, Kolch W (2007) MAP kinase signalling pathways in cancer. Oncogene 26:3279–3290. https://doi.org/10.1038/sj.onc.1210421

    Article  CAS  PubMed  Google Scholar 

  49. Marshall GM, Liu PY, Gherardi S et al (2011) SIRT1 promotes N-Myc oncogenesis through a positive feedback loop involving the effects of MKP3 and ERK on N-Myc protein stability. PLoS Genet 7:e1002135. https://doi.org/10.1371/journal.pgen.1002135

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Porta C, Paglino C, Mosca A (2014) Targeting PI3K/Akt/mTOR signaling in cancer. Front Oncol 4:64. https://doi.org/10.3389/fonc.2014.00064

    Article  PubMed  PubMed Central  Google Scholar 

  51. Pei JJ, Hugon J (2008) mTOR-dependent signalling in Alzheimer’s disease. J Cell Mol Med 12:2525–2532

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. White MC, Holman DM, Boehm JE et al (2014) Age and cancer risk: a potentially modifiable relationship. Am J Prev Med 46:S7-15. https://doi.org/10.1016/j.amepre.2013.10.029

    Article  PubMed  PubMed Central  Google Scholar 

  53. Guerreiro R, Bras J (2015) The age factor in Alzheimer’s disease. Genome Med 7:1–3. https://doi.org/10.1186/s13073-015-0232-5

    Article  CAS  Google Scholar 

  54. Musicco M, Adorni F, Di Santo S et al (2013) Inverse occurrence of cancer and Alzheimer disease: a population-based incidence study. Neurology 81:322–328. https://doi.org/10.1212/WNL.0b013e31829c5ec1

    Article  PubMed  Google Scholar 

  55. Majd S, Power J, Majd Z (2019) Alzheimer’s Disease and cancer: when two monsters cannot be together. Front Neurosci 13:155. https://doi.org/10.3389/fnins.2019.00155

    Article  PubMed  PubMed Central  Google Scholar 

  56. Hay N (2011) Interplay between FOXO, TOR, and Akt. Biochim Biophys Acta - Mol Cell Res 1813:1965–1970. https://doi.org/10.1016/j.bbamcr.2011.03.013

    Article  CAS  Google Scholar 

  57. Gómez-Crisóstomo NP, Rodríguez Martínez E, Rivas-Arancibia S (2014) Oxidative stress activates the transcription factors FoxO 1a and FoxO 3a in the hippocampus of rats exposed to low doses of ozone. Oxid Med Cell Longev 2014:805764. https://doi.org/10.1155/2014/805764

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Bullock M (2016) FOXO factors and breast cancer: outfoxing endocrine resistance. Endocr Relat Cancer 23:R113–R130. https://doi.org/10.1530/ERC-15-0461

    Article  CAS  PubMed  Google Scholar 

  59. Jiramongkol Y, Lam EWF (2020) FOXO transcription factor family in cancer and metastasis. Cancer Metastasis Rev 39:681–709. https://doi.org/10.1007/s10555-020-09883-w

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Chandramohan V, Jeay S, Pianetti S, Sonenshein GE (2004) Reciprocal control of forkhead box O 3a and c-Myc via the phosphatidylinositol 3-kinase pathway coordinately regulates p27 Kip1 levels. J Immunol 172:5522–5527. https://doi.org/10.4049/jimmunol.172.9.5522

    Article  CAS  PubMed  Google Scholar 

  61. Riddell M, Nakayama A, Hikita T et al (2018) aPKC controls endothelial growth by modulating c-Myc via FoxO1 DNA-binding ability. Nat Commun 9:5357. https://doi.org/10.1038/s41467-018-07739-0

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  62. Ariga H (2015) Common mechanisms of onset of cancer and neurodegenerative diseases. Biol Pharm Bull 38:795–808. https://doi.org/10.1248/bpb.b15-00125

    Article  CAS  PubMed  Google Scholar 

  63. Qin ZH, Chen RW, Wang Y et al (1999) Nuclear factor κB nuclear translocation upregulates c-Myc and p53 expression during NMDA receptor-mediated apoptosis in rat striatum. J Neurosci 19:4023–4033. https://doi.org/10.1523/jneurosci.19-10-04023.1999

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  64. Arendt T (2003) Synaptic plasticity and cell cycle activation in neurons are alternative effector pathways: the “Dr. Jekyll and Mr. Hyde concept” of Alzheimer’s disease or the yin and yang of neuroplasticity. Prog Neurobiol 71:83–248. https://doi.org/10.1016/j.pneurobio.2003.09.007

    Article  PubMed  Google Scholar 

  65. Klein JA, Ackerman SL (2003) Oxidative stress, cell cycle, and neurodegeneration. J Clin Invest 111:785–793. https://doi.org/10.1172/jci18182

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  66. Sheen J-H, Dickson RB (2002) Overexpression of c-Myc alters G1/S arrest following ionizing radiation. Mol Cell Biol 22:1819–1833. https://doi.org/10.1128/mcb.22.6.1819-1833.2002

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  67. Li Q, Dang CV (1999) c-Myc overexpression uncouples DNA replication from mitosis. Mol Cell Biol 19:5339–5351. https://doi.org/10.1128/mcb.19.8.5339

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  68. McGahan L, Hakim AM, Robertson GS (1998) Hippocampal Myc and p53 expression following transient global ischemia. Mol Brain Res 56:133–145. https://doi.org/10.1016/S0169-328X(98)00038-2

    Article  CAS  PubMed  Google Scholar 

  69. Purves D, Augustine GJ, Fitzpatrick D, Katz LC, LaMantia A-S, McNamaraWilliams JOSM (2001) Neuroscience, 2nd edn. Sinauer Associates, Sunderland

    Google Scholar 

  70. Belin S, Nawabi H, Wang C et al (2015) Injury-induced decline of intrinsic regenerative ability revealed by quantitative proteomics. Neuron 86:1000–1014. https://doi.org/10.1016/j.neuron.2015.03.060

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  71. Ma JJ, Ju X, Xu RJ et al (2019) Telomerase reverse transcriptase and p53 regulate mammalian peripheral nervous system and CNS axon regeneration downstream of c-Myc. J Neurosci 39:9107–9118. https://doi.org/10.1523/JNEUROSCI.0419-19.2019

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  72. Maciejowski J, De Lange T (2017) Telomeres in cancer: tumour suppression and genome instability. Nat Rev Mol Cell Biol 18:175–186. https://doi.org/10.1038/nrm.2016.171

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  73. Holtmaat A, Svoboda K (2009) Experience-dependent structural synaptic plasticity in the mammalian brain. Nat Rev Neurosci 10:647–658. https://doi.org/10.1038/nrn2699

    Article  CAS  PubMed  Google Scholar 

  74. Wang Y, Liu Y, Chen Y et al (2009) Peripheral nerve injury induces down-regulation of Foxo3a and p27 kip1 in rat dorsal root ganglia. Neurochem Res 34:891–898. https://doi.org/10.1007/s11064-008-9849-8

    Article  CAS  PubMed  Google Scholar 

  75. Hasmatali JD, De Guzman J, Johnston J et al (2020) FOXO3a as a sensor of unilateral nerve injury in sensory neurons ipsilateral, contralateral and remote to injury. Neural Regen Res 15:2353. https://doi.org/10.4103/1673-5374.284999

    Article  PubMed  PubMed Central  Google Scholar 

  76. Groves MJ, Schänzer A, Simpson AJ et al (2003) Profile of adult rat sensory neuron loss, apoptosis and replacement after sciatic nerve crush. J Neurocytol 32:113–122. https://doi.org/10.1023/B:NEUR.0000005596.88385.ec

    Article  CAS  PubMed  Google Scholar 

  77. Xian CJ, Zhou XF (1999) Neuronal-glial differential expression of TGF-α and its receptor in the dorsal root ganglia in response to sciatic nerve lesion. Exp Neurol 157:317–326. https://doi.org/10.1006/exnr.1999.7063

    Article  CAS  PubMed  Google Scholar 

  78. Santo EE, Paik J (2018) FOXO in neural cells and diseases of the nervous system. Curr Top Dev Biol 127:105–118. https://doi.org/10.1016/bs.ctdb.2017.10.002

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  79. Sun F, Park KK, Belin S et al (2011) Sustained axon regeneration induced by co-deletion of PTEN and SOCS3. Nature 480:372–375. https://doi.org/10.1038/nature10594

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  80. Tanaka EM, Ferretti P (2009) Considering the evolution of regeneration in the central nervous system. Nat Rev Neurosci 10:713–723. https://doi.org/10.1038/nrn2707

    Article  CAS  PubMed  Google Scholar 

  81. Singh MD, Raj K, Sarkar S (2014) Drosophila Myc, a novel modifier suppresses the poly(Q) toxicity by modulating the level of CREB binding protein and histone acetylation. Neurobiol Dis 63:48–61. https://doi.org/10.1016/j.nbd.2013.11.015

    Article  CAS  PubMed  Google Scholar 

  82. Nandakumar S, Grushko O, Buttitta LA (2020) Polyploidy in the adult drosophila brain. Elife 9:1–25. https://doi.org/10.7554/ELIFE.54385

    Article  Google Scholar 

  83. Tedeschi A, Omura T, Costigan M (2017) CNS repair and axon regeneration: using genetic variation to determine mechanisms. Exp Neurol 287:409–422. https://doi.org/10.1016/j.expneurol.2016.05.004

    Article  PubMed  Google Scholar 

Download references

Funding

This work was financially supported by the Serbian Ministry of Education, Science and Technological Research (Grant No. 175083).

Author information

Authors and Affiliations

  1. Western Serbia Academy of Applied Sciences, Uzice, Serbia

    Tatjana Marinkovic

  2. Faculty of Special Education and Rehabilitation, University of Belgrade, Visokog Stevana 2, 11000, Belgrade, Serbia

    Dragan Marinkovic

Authors
  1. Tatjana Marinkovic
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dragan Marinkovic
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

The idea for this article came from Dragan Marinkovic, while both authors contributed in literature search and data analysis, structuring, drafting, writing and critical revising.

Corresponding author

Correspondence to Dragan Marinkovic.

Ethics declarations

Ethics Approval and Consent to Participate

Not applicable for the review paper.

Consent for Publication

Not applicable for the review paper.

Conflict of Interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Marinkovic, T., Marinkovic, D. Obscure Involvement of MYC in Neurodegenerative Diseases and Neuronal Repair. Mol Neurobiol 58, 4169–4177 (2021). https://doi.org/10.1007/s12035-021-02406-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12035-021-02406-w

Keywords

Search

Navigation